Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126536261 | 12653626 | 1 | I | 2016 | 20160616 | 20160815 | 20160815 | PER | US-ASTRAZENECA-2016SE67183 | ASTRAZENECA | 65.00 | YR | F | Y | 0.00000 | 20160816 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126536261 | 12653626 | 1 | PS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | U | 21366 | 2.5 | MG | TABLET | QOD | ||||||
| 126536261 | 12653626 | 2 | C | METFORMIN HYDROCHLORIDE. | METFORMIN HYDROCHLORIDE | 1 | Oral | 0 | 1000 | MG | |||||||||
| 126536261 | 12653626 | 3 | C | METFORMIN HYDROCHLORIDE. | METFORMIN HYDROCHLORIDE | 1 | Oral | 0 | 500 | MG | |||||||||
| 126536261 | 12653626 | 4 | C | GLIPIZIDE ER | GLIPIZIDE | 1 | Oral | 0 | 7.5 | MG | QD | ||||||||
| 126536261 | 12653626 | 5 | C | GLIPIZIDE. | GLIPIZIDE | 1 | Oral | 0 | 2.5 | MG | QD | ||||||||
| 126536261 | 12653626 | 6 | C | LOSARTAN POTASSIUM. | LOSARTAN POTASSIUM | 1 | Oral | 0 | 100 | MG | QD | ||||||||
| 126536261 | 12653626 | 7 | C | OSTEOBIFLEX | 2 | Oral | 0 | 2 | MG | QD | |||||||||
| 126536261 | 12653626 | 8 | C | OSTEOBIFLEX | 2 | Oral | 0 | 2 | MG | QD | |||||||||
| 126536261 | 12653626 | 9 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | Oral | 0 | 2000 | MG | QD | ||||||||
| 126536261 | 12653626 | 10 | C | COQ10 | UBIDECARENONE | 1 | Oral | 0 | 100 | MG | QD | ||||||||
| 126536261 | 12653626 | 11 | C | GARLIC. | GARLIC | 1 | Oral | 0 | 2000 | MG | QD | ||||||||
| 126536261 | 12653626 | 12 | C | LORATIDINE | LORATADINE | 1 | Oral | 0 | 10 | MG | QD | ||||||||
| 126536261 | 12653626 | 13 | C | LACTAID | LACTASE | 1 | Oral | 0 | |||||||||||
| 126536261 | 12653626 | 14 | C | BEANO | ASPERGILLUS NIGER .ALPHA.-GALACTOSIDASE | 1 | Oral | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126536261 | 12653626 | 1 | Blood cholesterol abnormal |
| 126536261 | 12653626 | 2 | Diabetes mellitus |
| 126536261 | 12653626 | 3 | Diabetes mellitus |
| 126536261 | 12653626 | 4 | Diabetes mellitus |
| 126536261 | 12653626 | 5 | Diabetes mellitus |
| 126536261 | 12653626 | 6 | Hypertension |
| 126536261 | 12653626 | 7 | Myalgia |
| 126536261 | 12653626 | 8 | Arthralgia |
| 126536261 | 12653626 | 10 | Adjuvant therapy |
| 126536261 | 12653626 | 11 | Ill-defined disorder |
| 126536261 | 12653626 | 12 | Hypersensitivity |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126536261 | 12653626 | Arthralgia | |
| 126536261 | 12653626 | Blood cholesterol increased | |
| 126536261 | 12653626 | Body height decreased | |
| 126536261 | 12653626 | Crying | |
| 126536261 | 12653626 | Drug dose omission | |
| 126536261 | 12653626 | Fatigue | |
| 126536261 | 12653626 | Intentional product misuse | |
| 126536261 | 12653626 | Magnesium deficiency | |
| 126536261 | 12653626 | Moaning | |
| 126536261 | 12653626 | Musculoskeletal stiffness | |
| 126536261 | 12653626 | Myalgia | |
| 126536261 | 12653626 | Off label use | |
| 126536261 | 12653626 | Physical disability | |
| 126536261 | 12653626 | Rheumatoid factor increased | |
| 126536261 | 12653626 | Trigger finger |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126536261 | 12653626 | 1 | 2015 | 0 |